Company intelligence / Profile preview

Velocity Healthcare

Durham, North Carolina, United States

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

Velocity Clinical Research is a leading global integrated site network that manages and executes clinical trials for pharmaceutical and biotech sponsors. The company has announced positive topline results for several partnered programs, including aleniglipron (an oral GLP-1 receptor agonist) in obesity and mazdutide in metabolic disorders. It also played a significant role in the Phase 3 trials for COVID-19 vaccines.

Therapeutic areas: EndocrinologyCardiovascularNeurologyDermatologyInfectious DiseasesPulmonologyOncology
Modalities: Small moleculeVaccineMonoclonal antibodyBiologicPeptideMedical deviceAntibodyBispecific monoclonal antibody
Industry: Contract Research Organization

Partnerships

Structure TherapeuticsInnovent BiologicsLuminis HealthPrivia HealthVerified Clinical Trials

Beyond the preview

Go deeper on Velocity Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Velocity Healthcare.

Explore the full profile